CALIDA THERAPEUTICS

French tech company | Builders Republic

About

Biotech developing monoclonal antibodies to treat and prevent thrombo-inflammatory disorders — targeting conditions such as deep vein thrombosis, stroke and atherosclerosis, building on US academic research licensed from Cleveland.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2022
City
PARIS
Region
IDF
Tracked rounds
1
Amount raised
2.0 M€ raised since 2020

Funding rounds

  • Seed — 2023

Investors